Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Journal of
Clinical Psychiatry

Free access
Movement Disorders

Letter to the Editor November 15, 2007

A Case of Aripiprazole-Related Tardive Akathisia and Its Treatment With Ropinirole

John M. Hettema; David E. Ross

J Clin Psychiatry 2007;68(11):1814-1815

Article Abstract

Letter to the Editor

A Case of Aripiprazole-Related Tardive Akathisia and Its Treatment With Ropinirole

 

About the Authors

  • John M. Hettema
    View full profile
  • David E. Ross
    View full profile
Download Free PDF

This PDF is free for all visitors!

Related News Articles

Golf Course Living Linked To Higher Parkinson’s Risk? Global Parkinson’s Disease Cases to Surge by 2050 Weekly Mind Reader: Is It All Black and White?

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Detecting Tardive Dyskinesia Using Video-based AI Talking With Patients About TD Risk Pharmacologic Treatment of Tardive Dyskinesia

Related PCC Articles

Antipsychotic-Induced Lingual Dystonia With Bradycardia Etiology, Prevention, and Management of TD Phentermine-Related Tardive Dyskinesia
Cover of The Journal of Clinical Psychiatry, September 2025 issue, featuring article titles on postpartum distress, aripiprazole monohydrate injectables for schizophrenia and bipolar disorder, and other psychiatric topics.

Vol 86 • 2025 • Number 3

Read the Current Issue

Original Research

Treatment Use and Preference in a Diverse Sample of Women With Mood Disorders

Original Research

Klotho and Matrix Metalloproteinase-9 Levels and Their Association with Inhibitory Dyscontrol in Adolescents with First-Episode Major Affective Disorders

Original Research

Niacin-Induced Response in Early Psychosis

Original Research

Early Ketamine Response Reduces Suicidal Events at 3 Months

Letter to the Editor

Suicide Risk among Patients with Bipolar Disorder: Sleep Disruption versus Benzodiazepine Use

Original Research

Effect of Nature Videos on the Burden of Caregivers of Patients with Dementia

View current Issue

Related Articles

PCC
Letter to the Editor

Risperidone-Induced Tardive Dyskinesia in an Autistic Child

December 6, 2018

The majority of reported cases of risperidone-induced tardive dyskinesia occurred within 1 year after starting the neuroleptic. However, sometimes there was no cause-and-effect relationship of risperidone and tardive dyskinesia....
Vasco Kidd
PCC
Letter to the Editor

Paliperidone-Induced Meige Syndrome

January 26, 2017

Meige syndrome is a focal oral facial dystonia involving symmetrical blepharospasm and oromandibular dystonia. The typical symptom of the disorder is difficulty keeping the eyelids open. This report highlights...
João Gama Marques
PCC
Letter to the Editor

Covert Dyskinesia With Aripiprazole

June 9, 2016

Covert dyskinesia is a masked form of tardive dyskinesia that emerges only after antipsychotic drugs are withdrawn or reduced in dosage. Here, read the case of a 53-year-old man...
Ahmad Hameed, Andrew Francis, Yassir Mahgoub

Watch the New PsychCase360

Explore two real-world schizophrenia cases
Promotional banner for a video titled “Choosing the Right LAI for Patients With Schizophrenia” featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with a “Watch Now” button.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap